Status
Conditions
About
The main purpose is to describe how many children were treated during 24 months or less because of CPP and how treatment worked for them.
There are no participants in this trial, the study only involves reviewing participants medical past and current records and collecting information.
Full description
This is an observational, non-interventional, retrospective study to evaluate the participants characteristics, current treatment patterns and resource usage in Chinese pediatric participants diagnosed with CPP.
This study will enroll approximately 1000 participants.
The data available in an existing data source the Chinese CPP Big Data Platform database will be analyzed. All the participants will be assigned to a single observational cohort:
• Pediatric Participants With CPP
This multi-center trial will be conducted in China. The overall duration of the study will be approximately 3 years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Participants diagnosed with CPP and treated with GnRHa from the centers participating in this study within the Chinese CPP Big Data Platform database since 2015 to 2024.
CPP diagnosis is based on the clinical assessment and description by CPP specialized doctors.
Exclusion criteria
1,477 participants in 1 patient group
Loading...
Central trial contact
Takeda Contact
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal